Cart
sales@molnova.com
HIV-1 inhibitor 18A
CAS No. 331261-50-8
HIV-1 inhibitor 18A( Compound 18A )
Catalog No. M14111 CAS No. 331261-50-8
HIV-1 inhibitor 18A is a novel broad HIV-1 inhibitor that blocks envelope glycoprotein transitions critical for entry.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 218 | In Stock |
|
| 5MG | 227 | In Stock |
|
| 10MG | 313 | In Stock |
|
| 25MG | 535 | In Stock |
|
| 50MG | 736 | In Stock |
|
| 100MG | 1042 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHIV-1 inhibitor 18A
-
NoteResearch use only, not for human use.
-
Brief DescriptionHIV-1 inhibitor 18A is a novel broad HIV-1 inhibitor that blocks envelope glycoprotein transitions critical for entry.
-
DescriptionHIV-1 inhibitor 18A is a novel broad HIV-1 inhibitor that blocks envelope glycoprotein transitions critical for entry, specifically inhibits the entry of a wide range of HIV-1 isolates with mean IC50 of 6.4 uM; inhibits the CD4-induced disruption of quaternary structures at the trimer apex and the exposure of the gp41 HR1 coiled coil, does not interfere with CD4 or CCR5 binding.
-
In VitroCell Viability Assay Cell Line:PBMCs Concentration:0.01-10 μM Incubation Time:40-44 h Result:Inhibited infection of HIV-1JR-FL, with an IC50 value of 0.4 μM.
-
In Vivo——
-
SynonymsCompound 18A
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number331261-50-8
-
Formula Weight313.33
-
Molecular FormulaC14H11N5O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N/N=C/C1=CC=C(O)C=C1)NC2=CC=CC3=NSN=C32
-
Chemical NameN-2,1,3-Benzothiadiazol-4-yl-2-[(4-hydroxyphenyl)methylene]-hydrazinecarboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Herschhorn A, et al. Nat Chem Biol. 2014 Oct;10(10):845-52.
2. Berinyuy E, et al. J Recept Signal Transduct Res. 2016;36(2):119-29.
molnova catalog
related products
-
PF-3450074
PF-3450074 (PF74) is a small molecule HIV capsid protein, destabilized the viral capsid in vitro; acts at an early stage of HIV-1 infection and inhibits reverse transcription in target cells.
-
(Rac)-Telinavir
(Rac)-Telinavir shows anti-HIV activity.
-
Apelin-36 (rat, mous...
Endogenous APJ receptor agonist that is secreted by adipocytes. Binds with high affinity to APJ receptors (IC50 = 5.4 nM) and potently inhibits cAMP production in vitro (EC50 = 0.52 nM). Involved in regulation of cardiovascular function, fluid homeostasis and feeding. Blocks entry of some HIV-1 and HIV-2 strains into NP-2/CD4 cells expressing APJ.
